Dendritic Cell Immunotherapy for the Treatment of Neoplastic Disease
Open Access
- 28 February 2006
- journal article
- review article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 12 (2) , 113-125
- https://doi.org/10.1016/j.bbmt.2005.09.003
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- The large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC)Lung Cancer, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Boosting T Cell-Mediated Immunity to Tyrosinase by Vaccinia Virus-Transduced, CD34+-Derived Dendritic Cell VaccinationClinical Cancer Research, 2004
- T-cell anergyCurrent Opinion in Immunology, 2004
- Viral infection and Toll‐like receptor agonists induce a differential expression of type I and λ interferons in human plasmacytoid and monocyte‐derived dendritic cellsEuropean Journal of Immunology, 2004
- Intranodal Administration of Peptide-Pulsed Mature Dendritic Cell Vaccines Results in Superior CD8+T-Cell Function in Melanoma PatientsJournal of Clinical Oncology, 2003
- Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adultsPublished by Elsevier ,2003
- Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cellsLeukemia, 2003
- TSLP: finally in the limelightNature Immunology, 2002
- Idiotypic protein-pulsed dendritic cell vaccination in multiple myelomaInternational Journal of Cancer, 1999